DONATE MAINS

References

Berson EL : Management of retinitis pigmentosa. Retinal Physician, Wolters Kluwer Pharma Solutions, Inc.: www.retinalphysician.com. Accessed October, 2008.

Daiger SP, Bowne SJ, Sullivan LS : Perspective on genes and mutations causing retinitis pigmentosa. Arch Ophthalmol. 2007 February;125(2):151-158.

Delyfer MN, Léveillard T, Mohand-Saïd S, Hicks D, Picaud S, Sahel JA: Inherited retinal degenerations: therapeutic prospects. Biology of the Cell. 2004 May; 96(4):261-269.

Hartong DT, Berson EL, Dryja TP : Retinitis pigmentosa. The Lancet. 2006 November 18-24; 368(9549):1795-1809.

Pagon RA, Daiger SP : Retinitis pigmentosa overview. GeneTests. University of Washington; Seattle: http://www.GeneTests.org. Accessed September 16, 2005.

RetNet : Genes and Mapped Loci Causing Retinal Diseases (http://www.sph.uth.tmc.edu/RetNet/)

Shintani K, Shechtman DL, Gurwood AS: Review and update : Current treatment trends for patients with retinitis pigmentosa. Optometry, 2009 July; 80(7):384-401.

Yang Y, Mohand-Said S, Danan A, Simonutti M, Fontaine V, Clerin E, Picaud S, Léveillard T, Sahel JA: Functional cone rescue by RdCVF protein in a dominant model of retinitis pigmentosa. Molecular Therapy. 2009 May; 17(5):787-795.

Robson AG, El-Amir A, Bailey C, Egan CA, Fitzke FW, Webster AR, Bird AC, Holder GE. Pattern ERG correlates of abnormal fundus autofluorescence in patients with retinitis pigmentosa and normal visual acuity. Invest Ophthalmol Vis Sci. 2003 Aug;44(8):3544-3550.

Contributors: Katia Marazova, MD, PhD (février 2010), Pr José-Alain Sahel and Dr Isabelle Audo, MCU-PH

Disclaimer: This document contains information based on published scientific articles and is for educational purposes only. It is in no way intended as a substitute for qualified medical professional help, advice, diagnosis or treatment.